Weekly cisplatin - epirubicin - paclitaxel (PET) with G-CSF support vs. triweekly epirubicin-paclitaxel (ET) in advanced breast cancer (ABC). A SICOG phase III trial
G. Frasci, P. Comella, G. D'Aiuto, R. Thomas, I. Capasso, G. Botti, R.G. Cortino, L. Maiorino, L. Lapenta, G. ComellaVolume:
37
Year:
2001
Language:
english
DOI:
10.1016/s0959-8049(01)81044-3
File:
PDF, 341 KB
english, 2001